Guanpeng Qi

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials	2023	Zhaohang Li Ze Xu Aijun Zhang Guanpeng Qi Zuojing Li

Common Coauthors

Coauthor	Papers Together
Aijun Zhang	1
Zuojing Li	1
Ze Xu	1
Zhaohang Li	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Bayesian optimal interval design for dose finding in drug-combination trials	2015	Ruitao Lin Guosheng Yin	1
+ PDF Chat	A Dose–Schedule Finding Design for Phase I–II Clinical Trials	2015	Beibei Guo Yisheng Li Ying Yuan	1
+ PDF Chat	Model‐based phase I designs incorporating toxicity and efficacy for single and dual agent drug combinations: Methods and challenges	2010	Sumithra J. Mandrekar Rui Qin Daniel J. Sargent	1
+ PDF Chat	Dose-finding design for multi-drug combinations	2011	Nolan A. Wages Mark R. Conaway John O’Quigley	1
+ PDF Chat	Bayesian optimal interval designs for phase I clinical trials	2014	Suyu Liu Ying Yuan	1
+	A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents	2008	Guosheng Yin Ying Yuan	1
+ PDF Chat	Bayesian Dose Finding in Oncology For Drug Combinations by Copula Regression	2009	Guosheng Yin Ying Yuan	1
+ PDF Chat	A Bayesian Dose Finding Design for Clinical Trials Combining a Cytotoxic Agent with a Molecularly Targeted Agent	2014	Marie-Karelle Rivière Ying Yuan Frédéric Dubois Sarah Zohar	1
+	Dose‐Finding with Two Agents in Phase I Oncology Trials	2003	Peter F. Thall Randall E. Millikan Peter P. Mueller Sang Joon Lee	1
+	Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer	1990	John O’Quigley Margaret S. Pepe Lloyd D. Fisher	1
+ PDF Chat	A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents	2009	Thomas M. Braun Shufang Wang	1
+	Design Issues in Dose-Finding Phase I Trials for Combinations of Two Agents	2009	Shenghua Kelly Fan Alan P. Venook Ying Lü	1
+	Two‐Dimensional Dose Finding in Discrete Dose Space	2005	Kai Wang Anastasia Ivanova	1
+ PDF Chat	Phase I Drug Combination Trial Design: Walking the Tightrope	2009	Paul Hamberg Jaap Verweij	1
+ PDF Chat	Dose–schedule finding in phase I/II clinical trials using a Bayesian isotonic transformation	2008	Yisheng Li B. Nebiyou Bekele Yuan Ji John D. Cook	1
+	An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinations	2006	Sumithra J. Mandrekar Yue Cui Daniel J. Sargent	1
+	A non‐parametric approach to the design and analysis of two‐dimensional dose‐finding trials	2004	Anastasia Ivanova Kai Wang	1
+ PDF Chat	A practical Bayesian design to identify the maximum tolerated dose contour for drug combination trials	2016	Liangcai Zhang Ying Yuan	1
+	Comparative review of novel model‐assisted designs for phase I clinical trials	2018	Heng Zhou Thomas A. Murray Haitao Pan Ying Yuan	1
+	Keyboard design for phase I drug-combination trials	2020	Haitao Pan Ruitao Lin Yanhong Zhou Ying Yuan	1
+ PDF Chat	A phase I dose-finding design with incorporation of historical information and adaptive shrinking boundaries	2020	Chen Li Haitao Pan	1
+ PDF Chat	A comparison of model-free phase I dose escalation designs for dual-agent combination therapies	2024	Helen Barnett M. C. George Donia Skanji Gaëlle Saint‐Hilary Thomas Jaki Pavel Mozgunov	1
+ PDF Chat	An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials	2021	Rongji Mu Zongliang Hu Guoying Xu Haitao Pan	1